The need for standardized biobanks in Kazakhstan


 

 

New articles in this journal are licensed under a Creative Commons Attribution 3.0 United States License. 

 

 

This journal is published by the University Library System of the University of Pittsburgh as part  

of its D-Scribe Digital Publishing Program and is cosponsored by the University of Pittsburgh Press. 

 

 

 

 

 

 

 
 

 

 

 

 

 

 

The need for standardized 

biobanks in Kazakhstan 

 

 

Kuvat Momynaliev, Meruert 

Imanbekova 

 
1National Center for Biotechnology, 
Almaty, Kazakhstan

 

Vol. 2, Suppl. (2013)   |   ISSN 2166-7403 (online)    

DOI 10.5195/cajgh.2013.99   |   http://cajgh.pitt.edu 

http://www.library.pitt.edu/
http://www.pitt.edu/
http://www.library.pitt.edu/articles/digpubtype/index.html
http://www.upress.pitt.edu/upressIndex.aspx
http://creativecommons.org/licenses/by/3.0/us/


 

 

MOMYNALIEV 

 

 

This work is licensed under a Creative Commons Attribution 3.0 United States License. 

 

This journal is published by the University Library System of the University of Pittsburgh as part  

of its D-Scribe Digital Publishing Program and is cosponsored by the University of Pittsburgh Press. 

 

Central Asian Journal of Global Health 

Volume 2, Suppl. (2013)  |  ISSN 2166-7403 (online)  |  DOI 10.5195/cajgh.2013.99  |  http://cajgh.pitt.edu 

  

 

Abstract 

Biobanks are an important tool for clinical and research studies conducted on biomarkers of genetic therapy, diagnostic tests and 

new drugs; however, most biobanks remain incomplete and are often used without uniform standards and criteria. There is also a 

a lack of high-quality biological samples and many bioethical problems are often overlooked. 

 

Currently, Kazakhstan has no standard requirements and protocols for biomedical organizations. However, .an analysis of 

published data shows that possibly hundreds of samples are analyzed. Therefore, an establishment of biobank with standardized 

requirements could create better quality research.  

 

The National Center for Biotechnology has already started a biobank with more than 1,500 blood samples, with the ultimate goal 

of creating a biobank including around 10,000 blood samples of healthy volunteers, the same number of samples obtained from 

individuals with cardiovascular and endocrine diseases with samples stored under special conditions. The database contains 

demographic characteristics of donor’s medical history. Informed consent for research received from all donors. This biobank can 

be considered as a national resource for scientific research. 

Keywords: biobanks, biomedical organizations, scientific reseach, Kazakhstan 

 

 

 

http://www.library.pitt.edu/
http://www.pitt.edu/
http://www.library.pitt.edu/articles/digpubtype/index.html
http://www.upress.pitt.edu/upressIndex.aspx